Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 221, Issue 3, Pages 227-+Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2019.05.019
Keywords
alloimmunization; blood groups; fetal anemia; hemolysis; hemolytic disease of the fetus and newborn; hyperbilirubinemia; iso-immunization; prevention; Rh disease
Categories
Funding
- Kedrion Biopharma, Italy
Ask authors/readers for more resources
Severe morbidity and death because of Rh disease have only been reduced by approximately 50% globally during the last 50 years, despite the advent of anti-Rh(D) immunoglobin prophylaxis, which has resulted in > 160,000 perinatal deaths and 100,000 disabilities annually. This apparent failure to take appropriate preventive measures is of great concern. Thus, there is a great need to do much better. We wish to draw attention to the unnecessary continuing burden of Rh disease, to discuss some of the reasons for this failure, and to provide suggestions for a better way forward.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available